Single-Port Transaxillary Robotic Bilateral Total Thyroidectomy (START) for Graves’ Disease: First Initial 10 Cases Using da Vinci SP Robotic System
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Graves’ disease (GD) is an autoimmune disorder and the most common cause of persistent hyperthyroidism. Recently, robotic transaxillary thyroidectomy has served as a minimally invasive surgical alternative to conventional open thyroidectomy, even for patients with GD. In 2019, we first performed single-port transaxillary bilateral total thyroidectomy using the da Vinci SP robotic system (START). This study aimed to evaluate the technical feasibility of START for GD. Methods: This retrospective review included 10 patients with GD who underwent START at our institution between September 2020 and January 2022 by a single surgeon. Results: All 10 patients were female, and the body-mass index was 22.3±3.6 kg/m2 (range, 18.6–28.9). Seven patients (70%) had thyroid carcinoma, two (20%) had persistent hyperthyroidism despite medical control, and one patient (10%) had Graves’ ophthalmopathy. The mean operation time was 173.4±26.8 min (range, 128–226), and the mean estimated blood loss was 102.0±185.1 mL (range, 10–600). There were no cases of conversion to open surgery. There were no intraoperative complications and six cases of postoperative complications, including transient hypocalcemia in three cases, bleeding with reoperation in two cases, and transient hoarseness in one case. Conclusions: Patients with GD with large goiter and hypervascularity require delicate ligation, even of minor vessels, in a narrow space. START is feasible and safe for GD performed by high-volume expert surgeons.
Abstract
Purpose: Graves’ disease (GD) is an autoimmune disorder and the most common cause of persistent hyperthyroidism. Recently, robotic transaxillary thyroidectomy has served as a minimally invasive surgical alternative to conventional open thyroidectomy, even for patients with GD. In 2019, we first performed single-port transaxillary bilateral total thyroidectomy using the da Vinci SP robotic system (START). This study aimed to evaluate the technical feasibility of START for GD. Methods: This retrospective review included 10 patients with GD who underwent START at our institution between September 2020 and January 2022 by a single surgeon. Results: All 10 patients were female, and the body-mass index was 22.3±3.6 kg/m2 (range, 18.6–28.9). Seven patients (70%) had thyroid carcinoma, two (20%) had persistent hyperthyroidism despite medical control, and one patient (10%) had Graves’ ophthalmopathy. The mean operation time was 173.4±26.8 min (range, 128–226), and the mean estimated blood loss was 102.0±185.1 mL (range, 10–600). There were no cases of conversion to open surgery. There were no intraoperative complications and six cases of postoperative complications, including transient hypocalcemia in three cases, bleeding with reoperation in two cases, and transient hoarseness in one case. Conclusions: Patients with GD with large goiter and hypervascularity require delicate ligation, even of minor vessels, in a narrow space. START is feasible and safe for GD performed by high-volume expert surgeons.
참고문헌 (29)
- Weetman AP, "Graves’ disease", N Engl J Med, 343, pp.1236~1248 (2000)
- Bartley GB, "The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota", Trans Am Ophthalmol Soc, 92, pp.477~588 (1994)
- Abraham-Nordling M, "Incidence of hyperthyroidism in Sweden", Eur J Endocrinol, 165, pp.899~905 (2011)
- Tellez M, "Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin", Clin Endocrinol(Oxf), 36, pp.291~294 (1992)
- Tomer Y, "Mechanisms of autoimmune thyroid diseases : from genetics to epigenetics", Annu Rev Pathol, 9, pp.147~156 (2014)
- Bahn Chair RS, "Hyperthyroidism and other causes of thyrotoxicosis : management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists", Thyroid, 21, pp.593~646 (2011)
- Boostrom S, "Total thyroidectomy is the preferred treatment for patients with Graves’ disease and a thyroid nodule", Otolaryngol Head Neck Surg, 136, pp.278~281 (2007)
- Liu J, "Total thyroidectomy : a safe and effective treatment for Graves’ disease", J Surg Res, 168, pp.1~4 (2011)
- Yamamoto M, "Endoscopic subtotal thyroidectomy for patients with Graves’ disease", Surg Today, 31, pp.1~4 (2001)
- Berti P, "Video-assisted thyroidectomy for Graves’ disease : report of a preliminary experience", Surg Endosc, 18, pp.1208~1210 (2004)
- Sasaki A, "Endoscopic subtotal thyroidectomy: the procedure of choice for Graves’ disease?", World J Surg, 33, pp.67~71 (2009)
- Kang SW, "Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system : the operative outcomes of 338 consecutive patients", Surgery, 146, pp.1048~1055 (2009)
- Lee J, "Differences in postoperative outcomes, function, and cosmesis : open versus robotic thyroidectomy", Surg Endosc, 24, pp.3186~3194 (2010)
- Brunaud L, "Robotic thyroid surgery using a gasless transaxillary approach: cosmetic improvement or improved quality of surgical dissection?", J Visc Surg, 147, pp.e399~402 (2010)
- Ryu HR, "Feasibility and safety of a new robotic thyroidectomy through a gasless, transaxillary single-incision approach", J Am Coll Surg, 211, pp.e13~9 (2010)
- Giannopoulos G, "Robotic thyroidectomy for benign thyroid diseases : a stepwise strategy to the adoption of robotic thyroidectomy(gasless, transaxillary approach)", Surg Laparosc Endosc Percutan Tech, 23, pp.312~315 (2013)
- Noureldine SI, "Thyroidectomy for Graves’ disease : a feasibility study of the robotic transaxillary approach", ORL J Otorhinolaryngol Relat Spec, 75, pp.350~356 (2013)
- Kandil E, "Initial experience using robot-assisted transaxillary thyroidectomy for Graves’ disease", J Visc Surg, 148, pp.e447~51 (2011)
- Park JH, "Initial experience with robotic gasless transaxillary thyroidectomy for the management of graves disease : comparison of conventional open versus robotic thyroidectomy", Surg Laparosc Endosc Percutan Tech, 23, pp.e173~7 (2013)
- Bu Bshait MS, "Safety and feasibility of robotic transaxillary thyroidectomy for Graves’ disease : a retrospective cohort study", World J Surg (2022)
- Kim JK, "Single-port transaxillary robotic thyroidectomy(START) : 200-cases with two-step retraction method", Surg Endosc, 36, pp.2688~2696 (2022)
- 김훈엽, "Technical Instructions for Continuous Intraoperative Neural Monitoring in Thyroid Surgery", The Journal of Endocrine Surgery, 18(1), pp.61~78 (2018), 대한내분비외과학회[DOI]
- Agarwal S, "Feasibility and safety of a new robotic thyroidectomy through a gasless, transaxillary single-incision approach", J Am Coll Surg, 212, pp.1097~ (2011)
- Lee J, "Robotic thyroidectomy and neck dissection : past, present, and future", Cancer J, 19, pp.151~161 (2013)
- Kang SW, "Robot-assisted endoscopic surgery for thyroid cancer : experience with the first 100 patients", Surg Endosc, 23, pp.2399~2406 (2009)
- Kang SW, "Robot-assisted endoscopic thyroidectomy for thyroid malignancies using a gasless transaxillary approach", J Am Coll Surg, 209, pp.e1~7 (2009)
- Kandil EH, "Robotic transaxillary thyroidectomy : an examination of the first one hundred cases", J Am Coll Surg, 214, pp.558~564 (2012)
- Kim MJ, "Yonsei experience of 5000 gasless transaxillary robotic thyroidectomies", World J Surg, 42, pp.393~401 (2018)
- Al Qubaisi M, "Hypocalcemia after total thyroidectomy in graves disease", Perm J, 23, pp.23~ (2019)